Skip to search formSkip to main contentSkip to account menu

Microprolactinoma

Known as: Microprolactinomas 
A pituitary prolactin cell adenoma of less than 10 mm diameter. [HPO:probinson]
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Prolactinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Galactocele and prolactinoma--a pathogenic association?
Review
2004
Review
2004
Medical and Surgical Management of Microprolactinoma
A recent report by Colao et al. [1] indicates that a significant proportion of patients harboring prolactinomas treated with… 
2000
2000
Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution‐based assessment
The present study examines the LH secretory process in hyperprolactinaemic women before, during and after bromocriptine therapy… 
Highly Cited
2000
Highly Cited
2000
Long-term treatment of prolactin-secreting macroadenomas with pergolide.
Although most PRL-secreting pituitary tumors are microadenomas at presentation, many, and particularly those in men, are… 
Review
1991
Review
1991
Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas.
1988
1988
Suprasellar craniopharyngioma associated with hyperprolactinemia, pituitary lactotroph hyperplasia, and microprolactinoma. Case report.
A case with the coexistence of a microprolactinoma and suprasellar craniopharyngioma lactotroph hyperplasia is presented. Loss of… 
1986
1986
Ultrastructural morphometry of prolactin secreting adenomas treated with dopamine agonists.
Highly Cited
1985
Highly Cited
1985
Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
Thirty-six women with PRL-secreting pituitary microadenomas [mean PRL, 114 +/- 12.5 (+/- SE) ng/ml] were treated with… 
Highly Cited
1983
Highly Cited
1983
Natural history of microprolactinomas: six-year follow-up.
A 6-year follow-up of patients harboring microprolactinomas suggests that few patients (3 of 27) demonstrate significant growth… 
1983
1983
Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects.
The PRL inhibitory effect of dopamine (DA) in human in vivo studies has been previously demonstrated with DA infusions at rates… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)